Long-term outcomes after high-dose postprostatectomy salvage radiation treatment

International Journal of Radiation Oncology Biology Physics

Volumn 84, Issue 1, 2012, Pages 112-118

  Goenka, Anuj ^a   Magsanoc, Juan Martin ^a   Pei, Xin ^a   Schechter, Michael ^a   Kollmeier, Marisa ^a   Cox, Brett ^a   Scardino, Peter T ^a   Eastham, James A ^a   Zelefsky, Michael J ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

High dose salvage RT; IMRT; Postprostatectomy radiotherapy; Salvage radiotherapy

Indexed keywords

ANTIGENS; PATHOLOGY; UROLOGY;

ANDROGEN DEPRIVATION THERAPY; HIGH DOSE; HIGH DOSE RADIOTHERAPIES; IMRT; INDEPENDENT PREDICTORS; PROGRESSION FREE SURVIVAL; PROSTATE SPECIFIC ANTIGEN; SALVAGE RADIOTHERAPY;

RADIOTHERAPY;

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANDROGEN DEPRIVATION THERAPY; BIOCHEMICAL RECURRENCE FREE SURVIVAL; CANCER CONTROL; CANCER HORMONE THERAPY; CANCER INVASION; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CLINICAL ASSESSMENT; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED STUDY; DISTANT METASTASIS FREE SURVIVAL; FOLLOW UP; GLEASON SCORE; HIGH DOSE RADIOTHERAPY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; METASTASIS; OUTCOME ASSESSMENT; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROSTATE CANCER; PROSTATECTOMY; PROTEIN BLOOD LEVEL; RADIATION DOSE; RECURRENCE FREE SURVIVAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; SALVAGE THERAPY; SEMINAL VESICLE; STATISTICAL SIGNIFICANCE; TREATMENT FAILURE; TREATMENT RESPONSE;

EID: 84865677512     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.10.077     Document Type: Article

References (20)

1. A.J. Stephenson, S.F. Shariat, and M.J. Zelefsky Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy JAMA 291 2004 1325 1332
2. C.R. Pound, A.W. Partin, and M.A. Eisenberger Natural history of progression after PSA elevation following radical prostatectomy JAMA 281 1999 1591 1597
3. J.D. Cox, M.J. Gallagher, and E.H. Hammond Consensus statements on radiation therapy of prostate cancer: Guidelines for prostate re-biopsy after radiation and for radiation therapy with rising prostate-specific antigen levels after radical prostatectomy. American Society for Therapeutic Radiology and Oncology Consensus Panel J Clin Oncol 17 1999 1155
4. M. Bolla, H. van Poppel, and L. Collette Postoperative radiotherapy after radical prostatectomy: A randomised controlled trial (EORTC trial 22911) Lancet 366 2005 572 578
5. G.P. Swanson, M.A. Hussey, and C.M. Tangen Predominant treatment failure in postprostatectomy patients is local: Analysis of patterns of treatment failure in SWOG 8794 J Clin Oncol 25 2007 2225 2229
6. M.J. Zelefsky, L. Ben-Porat, and H.I. Scher Outcome predictors for the increasing PSA state after definitive external-beam radiotherapy for prostate cancer J Clin Oncol 23 2005 826 831
7. T. Wiegel, D. Bottke, and U. Steiner Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95 J Clin Oncol 27 2009 2924 2930
8. I.M. Thompson Jr., C.M. Tangen, and J. Paradelo Adjuvant radiotherapy for pathologically advanced prostate cancer: A randomized clinical trial JAMA 296 2006 2329 2335
9. A.L. Zietman, M.L. DeSilvio, and J.D. Slater Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: A randomized controlled trial JAMA 294 2005 1233 1239
10. D.A. Kuban, S.L. Tucker, and L. Dong Long-term results of the M. D. Anderson randomized dose-escalation trial for prostate cancer Int J Radiat Oncol Biol Phys 70 2008 67 74
11. M.J. Zelefsky, Z. Fuks, and M. Hunt High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer J Urol 166 2001 876 881
12. M.S. Anscher, R. Clough, and R. Dodge Radiotherapy for a rising prostate-specific antigen after radical prostatectomy: The first 10 years Int J Radiat Oncol Biol Phys 48 2000 369 375
13. J.R. Bernard Jr., S.J. Buskirk, and M.G. Heckman Salvage radiotherapy for rising prostate-specific antigen levels after radical prostatectomy for prostate cancer: Dose-response analysis Int J Radiat Oncol Biol Phys 76 2010 735 740
14. C.R. King, and M.T. Spiotto Improved outcomes with higher doses for salvage radiotherapy after prostatectomy Int J Radiat Oncol Biol Phys 71 2008 23 27
15. T.H. Van der Kwast, M. Bolla, and H. Van Poppel Identification of patients with prostate cancer who benefit from immediate postoperative radiotherapy: EORTC 22911 J Clin Oncol 25 2007 4178 4186
16. S.F. Shariat, S.M. Khoddami, and H. Saboorian Lymphovascular invasion is a pathological feature of biologically aggressive disease in patients treated with radical prostatectomy J Urol 171 2004 1122 1127
17. C.M. Herman, G.E. Wilcox, and M.W. Kattan Lymphovascular invasion as a predictor of disease progression in prostate cancer Am J Surg Pathol 24 2000 859 863
18. A.J. Stephenson, P.T. Scardino, and M.W. Kattan Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy J Clin Oncol 25 2007 2035 2041
19. W.U. Shipley, D. Hunt, and H. Lukka Initial report of RTOG 9601: A phase III trial in prostate cancer: Anti-androgen therapy (AAT) with bicalutamide during and after radiation therapy (RT) improves freedom from progression and reduces the incidence of metastatic disease in patients following radical prostatectomy (RP) with pT2-3, N0 disease, and elevated PSA levels Int J Radiat Oncol Biol Phys 78 2010 S27
20. T. Sella, L.H. Schwartz, and P.W. Swindle Suspected local recurrence after radical prostatectomy: Endorectal coil MR imaging Radiology 231 2004 379 385